AA
TARO

Ancient Art’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Ancient Art’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-87,980
Closed -$4.92M – 32
2013
Q2 		$4.92M Buy
+87,980
New +$5.2M 1.34% 21

Other funds holding TARO

AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
VCAM
Valentine Capital Asset Management Danville, California $89.6M AUM 0.84% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ancient Art's TARO Position: Q3 2013 in Review

Ancient Art sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2013, closing a stake of 87,980 shares — an estimated $4.92M sold.

Ancient Art first reported a position in TARO in Q2 2013 and held it in 1 quarter. The position peaked at $4.92M in Q2 2013. 47 funds tracked by Wall St. Rank hold TARO as of Q3 2013.

  • Ancient Art reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2013 after selling out during the quarter.
  • Ancient Art sold 87,980 Taro Pharmaceutical Industries Ltd. shares in Q3 2013, an estimated $4.92M.
  • Ancient Art first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 1 quarter.
  • Ancient Art's Taro Pharmaceutical Industries Ltd. position peaked at $4.92M in Q2 2013.
  • 47 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2013.

Based on Ancient Art's 13F filing for Q3 2013, filed 14 Nov 2013.